Webinar | July 21, 2022

The Future Of Aseptic Connections In Cell And Gene Therapies

Source: CPC

In a market where efficiencies, cost savings, repeatable processes and safety are vital, cell and gene therapy companies must routinely evaluate their processes and analyze where improvements can be made, even down to the way they are managing fluid transfer.

Originally presented live on July 19th and July 21st, CPC's Application Development Manager, Ray Rendon, examines open small format tubing in cell and gene therapy labs – and what technologies are on the horizon to help make more sterile connections going forward. He discussed the total cost of ownership of tube welded connections and single-use aseptic connectors and reviews vital evaluating criteria such capital expenditure, raw materials and utilities, but also dives deeper into considerations such as training, downtime, validations, and connection speed.

VIEW THE WEBINAR!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online